SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 87 filers reported holding SUTRO BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $642,644 | -60.5% | 185,200 | -47.0% | 0.00% | -50.0% |
| Q2 2023 | $1,626,105 | -16.5% | 349,700 | -17.0% | 0.00% | -20.0% |
| Q1 2023 | $1,946,406 | -37.1% | 421,300 | +10.0% | 0.01% | -44.4% |
| Q4 2022 | $3,095,448 | +60.5% | 383,100 | +10.2% | 0.01% | +50.0% |
| Q3 2022 | $1,929,000 | +42.2% | 347,500 | +33.4% | 0.01% | +50.0% |
| Q2 2022 | $1,357,000 | +54.4% | 260,500 | +143.7% | 0.00% | +100.0% |
| Q1 2022 | $879,000 | -37.3% | 106,900 | +13.4% | 0.00% | -50.0% |
| Q4 2021 | $1,403,000 | -51.9% | 94,300 | -38.9% | 0.00% | -50.0% |
| Q3 2021 | $2,915,000 | +70.5% | 154,300 | +67.7% | 0.01% | +60.0% |
| Q2 2021 | $1,710,000 | +25.6% | 92,000 | +53.8% | 0.01% | +25.0% |
| Q1 2021 | $1,361,000 | +46.2% | 59,800 | +39.4% | 0.00% | +100.0% |
| Q4 2020 | $931,000 | +121.7% | 42,900 | +2.6% | 0.00% | +100.0% |
| Q3 2020 | $420,000 | – | 41,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $34,466,000 | 16.86% |
| Samsara BioCapital, LLC | 1,675,579 | $31,652,000 | 4.97% |
| First Light Asset Management, LLC | 2,191,439 | $41,396,000 | 2.73% |
| FRAZIER MANAGEMENT LLC | 1,468,663 | $27,743,000 | 2.22% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,306,000 | 2.13% |
| Opaleye Management Inc. | 537,800 | $10,159,000 | 1.90% |
| Parkman Healthcare Partners LLC | 163,389 | $3,086,000 | 0.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,233,695 | $42,194,000 | 0.71% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 139,331 | $2,629,000 | 0.63% |
| BVF INC/IL | 826,825 | $15,619,000 | 0.61% |